Genzyme General

DigiGait Tackles Childhood Diseases.
Biotech Week; 11/18/2009; 1039 words; ...including Pfizer and Merck, Biotechnology Companies, including Genzyme and Vertex, and Academic Centers, including Yale and Northwestern...Sweadner, a Harvard Medical School Researcher at Massachusetts General Hospital, said, "DigiGait has been very useful in our research...

Fate Therapeutics Closes $30 Million Series B Financing.
PR Newswire; 11/16/2009; 1174 words; ...corporate investors, including Astellas Venture Management, Genzyme Ventures and a third undisclosed corporate investor. The three...testing at the Dana Farber Cancer Institute and Massachusetts General Hospital in adult patients with hematologic malignancies...

Osiris Therapeutics Reports Third Quarter 2009 Financial Results.(Financial report)
Diabetes Week; 11/16/2009; 1353 words; ...GvHD, and along with our partners at Genzyme, remain confident and committed to bringing...million in amortized license fees from Genzyme. For the third quarter of 2009, Osiris...incurred in the third quarter of 2008. General and administrative expenses were $1...

More contamination troubles for Genzyme ; Foreign particles found in drugs
The Boston Globe; 11/14/2009; 1359 words; ...that patients treated with Genzyme products have been exposed...senior vice president and general manager for genetic diseases at Genzyme, said particles are an issue...the "finishing" labs where Genzyme workers fill vials for shipment...

nation and world.(Front)
The Virginian Pilot; 11/14/2009; 897 words; ...the urging of state attorneys general from New York, California...FDA: Rubber and steel in Genzyme drugs WASHINGTON | Federal...particles of trash in drugs made by Genzyme, the second time this year...should return the product to Genzyme if they suspect contamination...